K-V Pharma (KV-A) Move Higher, May Be Related to Roche (RHHBY) News
K-V Pharmaceutical Company (NYSE: KV-A)(NYSE: KV-B) shares keep moving higher Friday, now up 13.5 percent.
The move might be related to the FDA issuing a letter revoking Roche's (OTCBB: RHHBY) Avastin breast cancer indication.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The move might be related to the FDA issuing a letter revoking Roche's (OTCBB: RHHBY) Avastin breast cancer indication.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Mylan (MYL) Launches Generic Bonviva Tabs (RHHBY) in Italy & the U.K.
- Apple (AAPL) Snubs Google (GOOG) in China, Opts for Competitor
- DryShips (DRYS) Trading Higher on Volatility, New Analyst Coverage
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
